SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1484Over the last month or so I've sold 1/2. I get wobbly knees when it comes tkeokalani'nui-1/12/2006
1483Well, as with a number of BTs this last month or so, it does seem to me as thougquidditch-1/12/2006
1482All that seemingly positive analysis and a $66 12-month target....keokalani'nui-1/12/2006
1481<< i wonder if the pfe ad policy speculation might be true.>> If yoNeuroInvestment-1/12/2006
1480from david woodburn, pru. i wonder if the pfe ad policy speculation might be trsoftware salesperson-1/12/2006
1479Neurocrine Provides Update of Food and Drug Administration's Review of Indipnigel bates-1/10/2006
1478Richard-You'll love this nomination--I nominate Donald Drakeman of Medarex aJOEBT1-1/9/2006
1477waiting for: Indiplon, a specific GABA-A agonist, is partnered with Pfizer formopgcw-1/7/2006
1476Biotech CEO of the Year, 2005 and two years running.... Michel deRosen, Virophscaram(o)uche-1/5/2006
1475>>The analyst expects a "strong launch" because of the partnershIcebrg-12/30/2005
1474Neurocrine's Indiplon Could See 'Strong Launch' Ed Lin, 12.30.05, 9JMarcus-12/30/2005
1473None of the original slate established on his watch. The best "got lemons,scaram(o)uche-12/22/2005
1472second the nomination. wild ride for that boy. phoenix.mopgcw-12/22/2005
1471>> Michel de Rosen << Under the circumstances, the silence re. nomiscaram(o)uche-12/22/2005
1470With Urocortin 2 for Congestive Heart Failure IND Filed for Second Phase IILJM-12/19/2005
1469Time to consider nominations for Biotech CEO of the Year, and it's traditionscaram(o)uche-12/16/2005
1468Thanks George, much appreciated...eomfred hayes-12/11/2005
1467Citigroup :NBIX: Indiplon Update--Revising Financial Model and Target Price mopgcw-12/11/2005
1466You are right on indi expected fda date. Also GnRh first P2 topline not expectekeokalani'nui-11/18/2005
1465Big pps move today on modest volume. Ward Knutson made a post on the momo threaquidditch-11/18/2005
1464With the quarterly results out of the door, directors are again free to buy and Icebrg-10/31/2005
1463as always..... thanks, sales. Rickscaram(o)uche-10/25/2005
1462Miljenko, i haven’t been following it that closely either, although it was mentsoftware salesperson-10/25/2005
1461Thnx for diging up info. In old days I would be doing that myself, but... it is Miljenko Zuanic-10/25/2005
1460>>MCH-1 program is silent for now, or it is discontinued?<< Not surtuck-10/24/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News